Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2004 10
2005 3
2006 3
2007 3
2008 2
2009 4
2010 5
2011 4
2012 2
2013 3
2014 5
2015 1
2016 8
2017 8
2018 7
2019 2
2020 4
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

77 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for daivobet
Your search for daivobetoi retrieved no results
[Clinical experience with Daivobet].
Cambazard F. Cambazard F. Ann Dermatol Venereol. 2004 May;131(5 Suppl):S9-13. doi: 10.1016/s0151-9638(04)93661-7. Ann Dermatol Venereol. 2004. PMID: 15179319 Review. French. No abstract available.
Calcipotriol and betamethasone dipropionate (Dovobet, Daivobet): a new formulation for the treatment of psoriasis.
Poulin Y. Poulin Y. Skin Therapy Lett. 2002 Jun;7(6):1-3. Skin Therapy Lett. 2002. PMID: 12223976 Review.
A new compound product containing calcipotriol 50 nanograms per gm and betamethasone dipropionate 0.5mg per gm (Dovobet, LEO Pharma) in an ointment base was recently introduced in Canada for the treatment of psoriasis. Known as Daivobet in Europe, it was introduced to the …
A new compound product containing calcipotriol 50 nanograms per gm and betamethasone dipropionate 0.5mg per gm (Dovobet, LEO Pharma) in an o …
Scalp psoriasis.
Kircik LH, Kumar S. Kircik LH, et al. J Drugs Dermatol. 2010 Aug;9(8 Suppl ODAC Conf Pt 2):s101-5. J Drugs Dermatol. 2010. PMID: 20715392 Review.
Feasibility Study for the Long-Term Management of Refractory Hyperkeratotic Eczema with Calcipotriol and Betamethasone Dipropionate (Daivobet()), Viaminate and Concomitant Conventional Therapies: A Retrospective Study.
Nabatanzi A, Mafuru M, Male M, Tian C, Zhang L, Wu T, Wu S, Huang C. Nabatanzi A, et al. Clin Cosmet Investig Dermatol. 2020 Oct 29;13:789-794. doi: 10.2147/CCID.S276148. eCollection 2020. Clin Cosmet Investig Dermatol. 2020. PMID: 33149651 Free PMC article.
We, therefore, incorporated Calcipotriol and Betamethasone Dipropionate (Daivobet()), and Viaminate into the mainstay treatment to improve the clinical symptoms. The study aimed to evaluate the efficacy of Daivobet () and Viaminate as a potential treatment alternati …
We, therefore, incorporated Calcipotriol and Betamethasone Dipropionate (Daivobet()), and Viaminate into the mainstay treatment to im …
Practicability of combined treatment with calcipotriol/betamethasone gel (Daivobet Gel) and improvement of quality of life in patients with psoriasis.
Sticherling M, Eicke C, Anger T. Sticherling M, et al. J Dtsch Dermatol Ges. 2013 May;11(5):420-7. doi: 10.1111/ddg.12029. Epub 2013 Feb 26. J Dtsch Dermatol Ges. 2013. PMID: 23437972 Clinical Trial.
The application of the study medication was 30% less time-consuming and handling associated with significantly higher patient satisfaction. Efficacy and tolerability of Daivobet Gel versus prior treatment were judged "very good" in 85.7% vs. 27.6% of patients. ...Patients …
The application of the study medication was 30% less time-consuming and handling associated with significantly higher patient satisfaction. …
Cost-effectiveness model of topical treatment of mild to moderate psoriasis vulgaris in Germany. A comparison of calcipotriol/betamethasone (Daivobet/Dovobet/Taclonex) once daily and a morning/evening non-fix combination of calcipotriol and betamethasone.
Augustin M, Peeters P, Radtke M, Moehling U, Lapp C. Augustin M, et al. Dermatology. 2007;215(3):219-28. doi: 10.1159/000106791. Dermatology. 2007. PMID: 17823519 Clinical Trial.
OBJECTIVE: To determine the cost-effectiveness of a fix calcipotriol/betamethasone combination (Daivobet/Dovobet/Taclonex) compared to a morning/evening non-fix calcipotriol/betamethasone combination in psoriasis treatment. ...Clinical and health resource utilisation data …
OBJECTIVE: To determine the cost-effectiveness of a fix calcipotriol/betamethasone combination (Daivobet/Dovobet/Taclonex) compared t …
A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet/Daivobet/Taclonex) in the treatment of psoriasis vulgaris.
Kragballe K, Austad J, Barnes L, Bibby A, de la Brassinne M, Cambazard F, Fleming C, Heikkilä H, Jolliffe D, Peyri J, Svensson A, Toole J, Wozel G. Kragballe K, et al. Br J Dermatol. 2006 Jun;154(6):1155-60. doi: 10.1111/j.1365-2133.2006.07236.x. Br J Dermatol. 2006. PMID: 16704648 Clinical Trial.
BACKGROUND: The calcipotriol/betamethasone dipropionate two-compound product Dovobet/Daivobet/Taclonex(LEO Pharma A/S, Ballerup, Denmark) has been shown to be safe and effective in the treatment of psoriasis for up to 8 weeks. ...
BACKGROUND: The calcipotriol/betamethasone dipropionate two-compound product Dovobet/Daivobet/Taclonex(LEO Pharma A/S, Ballerup, Denm …
Efficacy results of a 52-week, randomised, double-blind, safety study of a calcipotriol/betamethasone dipropionate two-compound product (Daivobet/Dovobet/Taclonex) in the treatment of psoriasis vulgaris.
Kragballe K, Austad J, Barnes L, Bibby A, de la Brassinne M, Cambazard F, Fleming C, Heikkilä H, Williams Z, Peyri Rey J, Svensson A, Toole J, Wozel G. Kragballe K, et al. Dermatology. 2006;213(4):319-26. doi: 10.1159/000096069. Dermatology. 2006. PMID: 17135738 Clinical Trial.
Spotlight on calcipotriene/betamethasone dipropionate in psoriasis vulgaris of the trunk, limbs, and scalp.
McCormack PL. McCormack PL. Am J Clin Dermatol. 2011 Dec 1;12(6):421-4. doi: 10.2165/11207670-000000000-00000. Am J Clin Dermatol. 2011. PMID: 21967117 Review.
Calcipotriene (calcipotriol)/betamethasone dipropionate (calcipotriene 50 mug/g and betamethasone 0.5 mg/g) is a fixed-dose combination of a vitamin D3 analog and a corticosteroid indicated for the once-daily, topical treatment of psoriasis vulgaris of the trunk, limbs, and scalp …
Calcipotriene (calcipotriol)/betamethasone dipropionate (calcipotriene 50 mug/g and betamethasone 0.5 mg/g) is a fixed-dose combination of a …
77 results